PharmaOps Global

Practical help with sterile injectables, quality control and drug‑device products.

PharmaOps Global advises manufacturers on building, scaling and fixing pharmaceutical operations, from the API and the filling line to the QC laboratory and the pen or autoinjector the patient holds.

Vial Cartridge Prefilled syringe Pen injector Autoinjector

The kind of questions clients bring

Most engagements start with a specific problem or decision. These are typical.

  • Our freeze-drying cycle worked at pilot scale. Why is the cake collapsing in the commercial dryer?
  • A new vial filling line is on order. Is the user requirement specification complete before we sign off?
  • Should we adopt a platform pen or autoinjector for our product, or develop our own?
  • Our QC laboratory has to be ready before a technology transfer. What is missing?
  • How do we bring our aseptic process in line with the current contamination control expectations?
  • Which vial, stopper or syringe system suits this biologic, and how do we show it holds integrity?
  • An audit found data integrity gaps in our QC laboratory. How do we fix them and keep them fixed?
  • We are qualifying a new API supplier. Can someone independent audit the site?

Services

Four areas of expertise, plus support for the projects that cut across them.

Injectable manufacturing

Vials, cartridges and prefilled syringes

Process design and scale-up
Formulation, filtration and filling processes taken from development to commercial batch sizes.
Aseptic filling and contamination control
Line performance, interventions and contamination control strategy for conventional lines, RABS and isolators.
Lyophilisation
Cycle development, transfer between freeze dryers, and resolving cake appearance and moisture problems.
Container closure systems
Choosing and evaluating vials, stoppers, syringes and cartridges for compatibility and integrity.

Quality control

Biologics and small-molecule generics, APIs and finished products

Gap analysis
An independent review of the QC laboratory's systems, methods and records against current GMP expectations.
Remediation
Planning and guiding the fixes after an audit or inspection finding, through to verified closure.
Data integrity checks
Reviewing audit trails, access controls and raw data practices on laboratory instruments and systems.
QC laboratory readiness
Equipment, workflows and staffing plans so the laboratory is ready when the product arrives.
Analytical method strategy
Chromatography, electrophoresis and bioassays for biologics; assay, impurity and dissolution methods for small molecules.
Method transfer
Moving methods between laboratories and partners without losing performance.

Delivery devices and combination products

Pens, autoinjectors and prefilled syringe systems

Device platform strategy
Comparing platform and custom devices against the drug, the patient and the business case.
Device development
User needs, design inputs, verification and design transfer for pen injectors and autoinjectors.
Drug and device integration
Matching formulation, primary container and device so the combined product performs as one.
Supplier and partner selection
Technical assessment of device makers and component suppliers.

API and supplier audits

Active pharmaceutical ingredients and their makers

API manufacturer audits
On-site GMP audits of active pharmaceutical ingredient manufacturers, with a clear report of findings and risks.
Supplier qualification support
Technical assessment of a new API source before you commit to it.

Projects and transfers

Support that spans every area

Technology transfer
Planning and running the transfer of products and processes between sites and partners.
Facility and line readiness
User requirement reviews, site assessments and readiness plans for new lines and plants.
Operational troubleshooting
Finding the root cause of yield, quality and reliability problems on existing lines.
Briefings for senior management
Clear technical assessments that help leadership decide on investments and partnerships.

How we work

You work directly with the founder from the first call to the final recommendation.

  1. Understand

    We review your product, site and constraints, on site where it helps, so the advice fits your situation.

  2. Advise

    You receive concise, prioritised findings with the reasoning behind them, written for both technical teams and management.

  3. Support

    We stay involved through implementation where you want it, until the decision has become a working result.

About the founder

PharmaOps Global was founded and is led by M S Elango. He has spent more than 25 years inside the plants, laboratories and development teams that make injectable medicines and the devices that deliver them.

He held senior roles at Biocon in India and Medtronic in the United States, and holds three U.S. patents. That mix of manufacturing, quality control and device experience is uncommon in one advisor, and it matters most on combination products, where the three have to work together.

The practice is based in Bangalore and works with manufacturers in India and the Gulf region.

Name
M S Elango
Qualifications
M.S., Ph.D., M.B.A.
Role
Founder & Principal
Experience
25+ years in injectables, quality control and devices
Earlier roles
Biocon (India) and Medtronic (USA)
Patents
3 U.S. patents
Based in
Bangalore, India
Clients in
India and the Gulf region

Tell us about your product or problem

Call M S Elango, Founder & Principal, or send a short note on what you are working on. A phone call is the quickest way to reach him.